BackgroundSchizophrenia frequently co-occurs with alcohol use disorder (AUD), resulting in a complex clinical profile associated with poor functional outcomes and reduced quality of life (QoL). Although both conditions independently impair psychosocial functioning, few studies have examined the combined effects of clinical, social, and treatment-related factors on QoL in patients with this dual diagnosis.MethodsThis prospective observational study included 88 male inpatients diagnosed with schizophrenia and comorbid AUD and who were followed over a 6-month period. Quality of life was assessed using the World Health Organization Quality of Life–BREF (WHOQoL–BREF). The clinical variables included severity of psychotic symptoms (Positive and Negative Syndrome Scale), alcohol use severity (Michigan Alcohol Screening Test), and treatment characteristics. Social and personal factors, such as self-care capacity, social support, education, and legal problems, were also evaluated. Multivariable regression analyses were conducted to identify predictors of QoL at baseline and follow-up.ResultsAt baseline, higher QoL was significantly associated with greater self-care capacity, social support, and higher positive symptom scores, while the need for antipsychotic treatment was associated with lower QoL. At the 6-month follow-up, better QoL was predicted by greater self-care capacity, higher educational level, and receipt of anti-craving medication. By contrast, negative and general psychopathology, medico-legal problems, and the need for antidepressant treatment were associated with poorer QoL. Alcohol use severity, as measured by the MAST, was not independently associated with QoL at either timepoint.ConclusionsIn patients with schizophrenia and comorbid AUD, QoL is shaped by a complex interaction of clinical severity, functional capacity, and treatment-related factors. Beyond symptom control, interventions targeting self-care, social functioning, and integrated addiction treatment appear essential to improve long-term outcomes. These findings support the implementation of a multidimensional, recovery-oriented approach for the management of patients with the dual diagnosis.
Internalizing and externalizing pathways to internet gaming disorder: the roles of anger and social anxiety
BackgroundInternet Gaming Disorder (IGD) represents a significant behavioral health concern, yet the roles of internalizing and externalizing psychological vulnerabilities in its development remain underexplored, particularly in Arabic-speaking populations.ObjectiveThis study examined anger and social anxiety as distinct externalizing and internalizing predictors of IGD severity in a Saudi Arabian community sample.MethodsA cross-sectional survey was administered to 303 participants (60.1% female; estimated mean age = 29.79 years, SD = 8.83) across five regions of Saudi Arabia. Participants completed the Internet Gaming Disorder Scale–Short Form (IGDS9-SF), a three-item Anger Screening Scale, and a two-item Social Anxiety screener. Hierarchical linear regression and structural equation modeling (SEM) were conducted to examine unique and incremental contributions of anger and social anxiety to IGD symptoms.ResultsAnger and social anxiety were strongly intercorrelated (r = .86, p <.001) but demonstrated divergent patterns in multivariate models. Hierarchical regression indicated that both predictors contributed unique variance when entered simultaneously, with anger positively and social anxiety negatively predicting IGD after controlling for shared variance. However, SEM clarified that only social anxiety significantly predicted latent IGD severity (β = .32, p = .027), whereas anger did not (β = .07, p = .68). The final model explained approximately 13% of variance in IGD symptoms.ConclusionsSocial anxiety was associated with IGD severity as a distinct internalizing correlate, consistent with avoidance-based coping and online social preference accounts. These preliminary, cross-sectional findings suggest that social anxiety warrants consideration in future IGD screening and research efforts in Arabic-speaking contexts.
Perception of social support and psychological well-being among mothers of individuals with intellectual disabilities: the mediating role of self-efficacy
BackgroundThe aim of this study is to examine the mediating role of self-efficacy in the relationship between social support perception and psychological well-being among mothers of individuals with intellectual disabilities.MethodsA correlational survey model was used in this study in line with the research objectives. The study group consisted of mothers of individuals with intellectual disabilities (n=80) in two central districts of Malatya province. Convenience sampling was employed in the study. The Psychological Well-being Scale was used to measure the psychological well-being of the participating mothers, the “Perceived Support Scale for Families of Children with Disabilities” was used to measure their perceived levels of social support, and the “Parental Self-Efficacy Scale” was used to measure their self-efficacy. In addition, a personal information form was used to introduce the socio-demographic characteristics of the participants. Descriptive statistics were calculated for the variables, and the normality assumption was examined using the Kolmogorov-Smirnov and Shapiro-Wilk tests. The relationships between the variables were evaluated using Pearson’s product-moment correlation analysis. Mediation analyses were performed using the PROCESS Macro (Model 4) developed by Hayes, and the significance of indirect effects was tested using the bootstrap method (5000 samples). The internal consistency reliability of the scales used in this study sample was assessed using Cronbach’s alpha coefficient.ResultsThere are positive and significant relationships between each of the perceived social support sub-dimensions of appreciation, informational, emotional, and companionship and self-efficacy (r = 0.28–0.36; p <0.05). A positive and significant relationship was also found between the total perceived social support score and self-efficacy (r = 0.37, p <0.01). In contrast, no direct significant relationships were found between perceived social support and its sub-dimensions and psychological well-being (p> 0.05). Psychological well-being showed only a moderate, positive and significant relationship with self-efficacy (r = 0.45, p <0.01).ConclusionsIn conclusion, it can be said that the relationship between perceived social support and psychological well-being is not direct, but indirect, mediated by self-efficacy.
From cats to cortex: T. gondii and psychosis, depression, and anxiety
This review examines whether cat ownership, via exposure to the neurotropic parasite T. gondii, contributes to vulnerability for psychotic, depressive, and anxiety symptoms. T. gondii establishes lifelong latent infection in the brain and muscle, where it can modulate dopaminergic signaling, neuroinflammation, and tryptophan–kynurenine metabolism, providing a biologically plausible pathway to altered cognition, mood, and behavior. Epidemiological and meta-analytic data indicate small-to-moderate associations between T. gondii seropositivity and schizophrenia, with more variable but suggestive links to depression and anxiety. Evidence for cat ownership as an independent risk factor is inconsistent: some cohorts and recent meta-analyses report elevated odds of schizophrenia-related outcomes in those exposed to cats, whereas rigorously controlled studies frequently find attenuated or null effects. Methodological limitations, alternative explanations, and cultural implications are discussed, and priorities for mechanism-informed, longitudinal and interventional research are outlined.
Deep peptide recognition profiling decodes TCR specificity and enables disease-associated antigen discovery
Nature Biotechnology, Published online: 13 May 2026; doi:10.1038/s41587-026-03128-x
A deep-learning method predicts T cell receptor specificity and disease-associated antigens.
Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models
Nature Biotechnology, Published online: 13 May 2026; doi:10.1038/s41587-026-03115-2
Immune-remodeling mRNAs delivered in lipid nanoparticles boost antitumor immunity.
Fluctuating internal states mediate neural–behavioral covariations in V1
Nature Neuroscience, Published online: 13 May 2026; doi:10.1038/s41593-026-02296-y
The authors report surprising covariations between subthreshold activity of single V1 neurons and behavior, demonstrating that interactions between external sensory inputs and internal states are implemented by a nonlinear modulatory signal in V1.
Closed-loop stimulation modulates attention shifting in children
Nature Neuroscience, Published online: 13 May 2026; doi:10.1038/s41593-026-02294-0
Intracranial recordings in children revealed neural signals predicting attentional lapses. Closed-loop stimulation rescued performance and scalp EEG enabled noninvasive modulation, identifying a reproducible marker of attentional control.
Extreme heat is worsening faster for Black Americans
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
Good morning. After what sometimes felt like endless speculation, FDA Commissioner Marty Makary resigned from his role yesterday. Kyle Diamantas, the agency’s top food regulator, will step in as acting commissioner. STAT’s Lizzy Lawrence has the details. And Matt Herper has a hot take: Marty Makary was the worst FDA commissioner in 25 years.
STAT+: Drug meant to make gene therapy safer may also make it less effective
BOSTON — A medicine increasingly used to mitigate the risk of deadly gene therapy side effects could also blunt the therapy’s effectiveness, a new study finds.
The trial, from the startup Encoded Therapeutics, tested a gene therapy for Dravet syndrome, a severe form of genetic epilepsy. A key concern in gene therapy trials is that patients could mount an immune response against the engineered viruses used to deliver new genes into the brain.
In the study, Encoded assigned most of the 21 children in the trial to receive steroids, the most commonly used immune suppressant. A subset — including most of the patients on the highest dose level — were assigned to also receive sirolimus, also known as rapamycin, a drug historically given to prevent rejection in transplant recipients.